New methods in molecular and cell biology, in analytics (including Process Analytical Techniques (PATs)), in process miniaturization, and in automation promise to make process development more efficient. This technological progress provides new ways to shorten timelines for large-molecule manufacturing process development and to reach proof-of-concept decision points earlier in clinical studies, ultimately reducing time to market.
Genedata Bioprocess is especially designed to meet the challenges associated with these new methods and technologies. It supports miniaturized screening approaches in scale-down models, such as micro-bioreactors or other unit operations. With a scalable architecture, it can capture the increasing amount of analytical data coming from different measurement devices, bioreactors, and other unit operations. The system can be directly integrated with laboratory equipment, including liquid handling systems, screening robots, bioreactors, and analytical devices. Information originating from different sources and systems is automatically processed, analyzed, and shared between different teams, including cell line development, upstream, downstream, formulation, and analytical development groups.